UK markets closed
All screeners/

Day Losers - US

Matching Stocks1-25 of 93 results
Share
Results were generated a few mins ago. Pricing data is updated frequently. Currency in USD
Symbol
NamePrice (intraday)Change% changeVolumeAvg vol (3-month)Market CapPE ratio (TTM)52-week range
IQ
iQIYI, Inc.18.37-3.31-15.27%34.269M8.873M13.477B17.33
GSX
GSX Techedu Inc.84.91-15.09-15.09%5.491M6.587M20.263BN/A
NOVA
Sunnova Energy International Inc.25.01-3.19-11.29%4.252M849,3032.127BN/A
RLLCF
Rolls-Royce Holdings plc0.0060-0.0007-10.45%547,2553.72M130.804BN/A
ADCT
ADC Therapeutics SA39.01-3.29-7.78%85,029292,5852.759BN/A
RLAY
Relay Therapeutics, Inc.33.90-2.50-6.87%138,498789,5233.146BN/A
DKNG
DraftKings Inc.33.67-2.38-6.60%18.033M14.147M11.914BN/A
BIDU
Baidu, Inc.116.52-8.05-6.46%6.499M4.156M40.16B9.08
HCM
Hutchison China MediTech Limited31.08-2.07-6.24%106,179309,6764.311BN/A
IIVI
II-VI Incorporated46.78-3.07-6.16%2.172M2.08M4.816BN/A
TTM
Tata Motors Limited8.22-0.50-5.73%1.212M2.576M5.411B4.25
DAO
Youdao, Inc.36.62-1.98-5.14%272,377342,5044.092BN/A
PDD
Pinduoduo Inc.84.43-4.42-4.97%3.144M9.161M101.116BN/A
HALO
Halozyme Therapeutics, Inc.28.13-1.50-5.06%453,0391.281M3.855BN/A
SSL
Sasol Limited8.41-0.45-5.08%1.011M3.607M5.38B8.03
SRNE
Sorrento Therapeutics, Inc.12.28-0.73-5.57%28.55M53.408M2.973BN/A
TAL
TAL Education Group73.40-3.71-4.81%968,7303.257M44.068BN/A
DCPH
Deciphera Pharmaceuticals, Inc.44.94-2.31-4.89%101,122456,2002.534BN/A
MCRB
Seres Therapeutics, Inc.27.14-1.44-5.04%1.591M2.698M2.07BN/A
COGNY
Cogna Educação S.A.1.2700-0.0600-4.51%48,032113,2452.516BN/A
AZPN
Aspen Technology, Inc.120.70-5.42-4.30%326,193516,4018.159B35.93
ICAGY
International Consolidated Airlines Group, S.A.5.14-0.23-4.29%87,346230,7145.069B1.61
TKC
Turkcell Iletisim Hizmetleri A.S.5.22-0.23-4.22%1.366M548,8874.472B7.01
SDGR
Schrödinger, Inc.70.00-3.07-4.20%1.344M1.12M4.432BN/A
AG
First Majestic Silver Corp.11.38-0.49-4.13%3.084M7.409M2.433BN/A
Show 25 rows
By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more